Taylor Collison

Taylor Collison

Taylor Collison was established in Adelaide in 1951 as a traditional stockbroking partnership, embedding itself into the fabric of South Australia's financial community for over seven decades. The firm operates as a participant of the Australian Securities Exchange (ASX), executing trades and providing corporate advice to a client base that spans private wealth, institutional investors, and the local corporate sector. The Collison family name remains associated with the firm's governance, anchoring its identity as a legacy financial services house in a market largely consolidated by major banks. The firm's primary business is institutional and retail stockbroking, executing across Australian equities and offering corporate advisory services to small and mid-cap ASX-listed companies. A distinctive arm of the firm is its venture capital activity, which concentrates on early-stage life sciences, biotechnology, and niche technology companies, often sourcing from South Australia's university and research-hospital ecosystems. Taylor Collison has acted as lead manager or co-manager for capital raisings in the pre-IPO and IPO stages for ventures in medical devices and therapeutics. The geographic focus is domestic Australia, with portfolio companies drawing from Adelaide, Melbourne, and Sydney innovation precincts. As a private entity, Taylor Collison does not disclose assets under management or total deployment figures. The firm maintains a single headquarters in Adelaide and draws its advisory talent from veterans of Australian equity markets and corporate finance. Its venture capital book is managed through dedicated vehicles that invest directly in company equity, with a horizon typical of life-sciences funding cycles. In August 2023, Taylor Collison acted as Joint Lead Manager for a capital raising by an ASX-listed life sciences company (per public record, ASX filings, 2023), reinforcing its ongoing role in bridging private Australian innovation to public market capital. Structurally, Taylor Collison differs from the typical Australian financial planning conglomerate by retaining its partnership-origin DNA and operating an active, in-house venture capital engine. Most small Australian brokerages shrunk into advisory-only models; Taylor Collison maintained a proprietary principal-investing track record alongside its client-facing broking desk, creating a dual revenue model uncommon among independent Australian securities firms of its vintage.